The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Discuva Ltd. / See Company Profile

Acquisition / Summit Therapeutics buys Discuva for cash and stock / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Jan. 3, 2018

Alliance / Roche targets multi-drug resistant Gram-negative bacteria in Discuva deal; extended / Strategic Transactions / Deal Date: Feb. 1, 2014 / Update Date: Feb. 1, 2017

Roivant Sciences GMBH / See Company Profile

Alliance / Roivant gets rights to HanAll's autoimmune disease candidate / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 23, 2017

Alliance / Arbutus receives $116mm investment from Roivant for HBV pipeline / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Alliance / AZ off-loads deprioritized project to Roivant / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Dicerna Pharmaceuticals Inc. / See Company Profile

Financing / Dicerna nets $37.6mm via FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 19, 2017

Alliance / Dicerna partners with BI to develop hepatic therapeutics / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 3, 2017

Financing / Dicerna secures $70mm in convertible stock financing / Strategic Transactions / Deal Date: Mar. 1, 2017 / Publish Date: Apr. 3, 2017


Medical Devices

Email Alert | RSS Feed

Harpoon Medical Inc. / See Company Profile

Acquisition / Edwards shells out $100mm up front for Harpoon Medical / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 8, 2017

Financing / Series A brings in $3.2mm so far for Harpoon Medical; Univ. of MD, Baltimore adds $100k / Strategic Transactions / Deal Date: Sep. 1, 2014 / Update Date: Nov. 1, 2014

Alliance / Harpoon Medical gets mitral valve repair IP from University of Maryland, Baltimore / Strategic Transactions / Deal Date: Feb. 1, 2014 / Publish Date: Mar. 14, 2014

Entellus Medical Inc. / See Company Profile

Acquisition / Stryker to acquire Entellus Medical for $24 per share / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 9, 2017

Acquisition / Entellus Medical pays cash and stock for Spirox / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Jul. 10, 2017

Financing / Device company Entellus Medical nets $37.6mm in FOPO / Strategic Transactions / Deal Date: Jan. 1, 2017 / Publish Date: Jan. 28, 2017


In Vitro Diagnostics

Email Alert | RSS Feed

Qiagen NV / See Company Profile

Alliance / Oxford Immunotec, Qiagen settle patent litigation / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 20, 2017

Alliance / Angle PLC and Qiagen co-promote circulating tumor cell testing systems / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 20, 2017

Alliance / Johns Hopkins grants immuno-oncology biomarker rights to Qiagen / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 7, 2017

Leica Biosystems Ltd. / See Company Profile

Alliance / Leica and Clearbridge co-promote circulating tumor cell analysis products / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 23, 2017

Alliance / Devicor licenses exclusive distribution rights to Endomagnetics' Sentimag surgical guidance system / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Sep. 2, 2016

Alliance / Leica Biosystems will exclusively sell Novacyt's NOVAPrep in China / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Mar. 12, 2015

Akers Biosciences Inc. / See Company Profile

Financing / Diagnostics company Akers Biosciences nets $6.4mm in FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 21, 2017

Alliance / First Check to distribute Akers' cholesterol test in the US / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 3, 2016

Alliance / Akers Biosciences and Hainan Savy Investment create diagnostics JV in China / Strategic Transactions / Deal Date: Oct. 1, 2014 / Publish Date: Nov. 20, 2014


Pharmaceuticals

Email Alert | RSS Feed

Autifony Therapeutics Ltd. / See Company Profile

Alliance / BI enters into CNS platform/drug collaboration with GSK spin-out Autifony / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 20, 2017

Financing / GSK spins off Autifony, which gets £10mm in a Series A commitment; round totals £23.75mm / Strategic Transactions / Deal Date: Aug. 1, 2011 / Update Date: Jul. 1, 2015

Alliance / GSK invests £1.25mm in hearing loss spin-out Autifony, out-licenses candidates / Strategic Transactions / Deal Date: Aug. 1, 2011 / Publish Date: Aug. 26, 2011

Global Blood Therapeutics Inc. / See Company Profile

Financing / Global Blood nets $96.3mm through follow-on offering / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 22, 2017

Financing / Global Blood nets $136mm through upsized public stock sale / Strategic Transactions / Deal Date: Feb. 1, 2017 / Publish Date: Feb. 24, 2017

Financing / Global Blood nets $112.8mm through public offering / Strategic Transactions / Deal Date: Jun. 1, 2016 / Publish Date: Jun. 22, 2016

ANI Pharmaceuticals Inc. / See Company Profile

Alliance / ANI pays $46.5mm for US rights to four of AZ's drugs / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Jan. 4, 2018

Alliance / Merck sells corticotropin NDAs to ANI for $75mm / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Jan. 6, 2016

Alliance / ANI acquires Teva's approved ANDA for anti-arrhythmic flecainide / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Mar. 19, 2015

Biotechnology

Biotechnology

Email Alert | RSS Feed

Discuva Ltd. / See Company Profile

Acquisition / Summit Therapeutics buys Discuva for cash and stock / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Jan. 3, 2018

Alliance / Roche targets multi-drug resistant Gram-negative bacteria in Discuva deal; extended / Strategic Transactions / Deal Date: Feb. 1, 2014 / Update Date: Feb. 1, 2017

Roivant Sciences GMBH / See Company Profile

Alliance / Roivant gets rights to HanAll's autoimmune disease candidate / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 23, 2017

Alliance / Arbutus receives $116mm investment from Roivant for HBV pipeline / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Alliance / AZ off-loads deprioritized project to Roivant / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Dicerna Pharmaceuticals Inc. / See Company Profile

Financing / Dicerna nets $37.6mm via FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 19, 2017

Alliance / Dicerna partners with BI to develop hepatic therapeutics / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 3, 2017

Financing / Dicerna secures $70mm in convertible stock financing / Strategic Transactions / Deal Date: Mar. 1, 2017 / Publish Date: Apr. 3, 2017

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Harpoon Medical Inc. / See Company Profile

Acquisition / Edwards shells out $100mm up front for Harpoon Medical / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 8, 2017

Financing / Series A brings in $3.2mm so far for Harpoon Medical; Univ. of MD, Baltimore adds $100k / Strategic Transactions / Deal Date: Sep. 1, 2014 / Update Date: Nov. 1, 2014

Alliance / Harpoon Medical gets mitral valve repair IP from University of Maryland, Baltimore / Strategic Transactions / Deal Date: Feb. 1, 2014 / Publish Date: Mar. 14, 2014

Entellus Medical Inc. / See Company Profile

Acquisition / Stryker to acquire Entellus Medical for $24 per share / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 9, 2017

Acquisition / Entellus Medical pays cash and stock for Spirox / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Jul. 10, 2017

Financing / Device company Entellus Medical nets $37.6mm in FOPO / Strategic Transactions / Deal Date: Jan. 1, 2017 / Publish Date: Jan. 28, 2017

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Qiagen NV / See Company Profile

Alliance / Oxford Immunotec, Qiagen settle patent litigation / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 20, 2017

Alliance / Angle PLC and Qiagen co-promote circulating tumor cell testing systems / Strategic Transactions / Deal Date: Sep. 1, 2017 / Publish Date: Sep. 20, 2017

Alliance / Johns Hopkins grants immuno-oncology biomarker rights to Qiagen / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 7, 2017

Leica Biosystems Ltd. / See Company Profile

Alliance / Leica and Clearbridge co-promote circulating tumor cell analysis products / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 23, 2017

Alliance / Devicor licenses exclusive distribution rights to Endomagnetics' Sentimag surgical guidance system / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Sep. 2, 2016

Alliance / Leica Biosystems will exclusively sell Novacyt's NOVAPrep in China / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Mar. 12, 2015

Akers Biosciences Inc. / See Company Profile

Financing / Diagnostics company Akers Biosciences nets $6.4mm in FOPO / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 21, 2017

Alliance / First Check to distribute Akers' cholesterol test in the US / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 3, 2016

Alliance / Akers Biosciences and Hainan Savy Investment create diagnostics JV in China / Strategic Transactions / Deal Date: Oct. 1, 2014 / Publish Date: Nov. 20, 2014

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Autifony Therapeutics Ltd. / See Company Profile

Alliance / BI enters into CNS platform/drug collaboration with GSK spin-out Autifony / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 20, 2017

Financing / GSK spins off Autifony, which gets £10mm in a Series A commitment; round totals £23.75mm / Strategic Transactions / Deal Date: Aug. 1, 2011 / Update Date: Jul. 1, 2015

Alliance / GSK invests £1.25mm in hearing loss spin-out Autifony, out-licenses candidates / Strategic Transactions / Deal Date: Aug. 1, 2011 / Publish Date: Aug. 26, 2011

Global Blood Therapeutics Inc. / See Company Profile

Financing / Global Blood nets $96.3mm through follow-on offering / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Dec. 22, 2017

Financing / Global Blood nets $136mm through upsized public stock sale / Strategic Transactions / Deal Date: Feb. 1, 2017 / Publish Date: Feb. 24, 2017

Financing / Global Blood nets $112.8mm through public offering / Strategic Transactions / Deal Date: Jun. 1, 2016 / Publish Date: Jun. 22, 2016

ANI Pharmaceuticals Inc. / See Company Profile

Alliance / ANI pays $46.5mm for US rights to four of AZ's drugs / Strategic Transactions / Deal Date: Dec. 1, 2017 / Publish Date: Jan. 4, 2018

Alliance / Merck sells corticotropin NDAs to ANI for $75mm / Strategic Transactions / Deal Date: Jan. 1, 2016 / Publish Date: Jan. 6, 2016

Alliance / ANI acquires Teva's approved ANDA for anti-arrhythmic flecainide / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Mar. 19, 2015

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel